This mini-review will discuss the recent advances concerning the role of apelin on energy metabolism particularly in pathophysiological situations (obesity, type 2 diabetes) and will try to establish a link between plasma apelin concentrations and metabolic diseases in humans. This evidence concerns the gene APLN and type 2 diabetes mellitus.